Weihong Zhang

Title: Weihong Zhang: Innovator in Pharmaceutical Chemistry

Introduction

Weihong Zhang is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, Zhang's work focuses on addressing critical health issues through his inventions.

Latest Patents

Zhang's latest patents include "Salt of EGFR inhibitor, crystalline form and uses thereof" and "Aminoquinazoline derivatives and their salts and methods of use." The first patent relates to a salt, hydrate, or crystalline form of an EGFR inhibitor, specifically targeting the treatment of proliferative disorders. The second patent involves aminoquinazoline derivatives that modulate protein tyrosine kinase activity, offering potential treatments for hyperproliferative disorders in mammals, especially humans.

Career Highlights

Zhang is currently associated with Sunshine Lake Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic options that can significantly impact patient care and treatment outcomes.

Collaborations

Zhang collaborates with talented individuals such as Yingjun Zhang and Bing Liu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Weihong Zhang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to advancing medical science. His work not only showcases his inventive spirit but also aims to improve health outcomes for patients worldwide.